Status: Recruiting
Suitability of a High-energy, Low-protein Formula (Renalive® LP)
Inclusion criteria (1) Diagnosed with chronic kidney disease stage 3b-5 (with history of eGFR\<45 mL/min/1.73 m2) Exclusion criteria (1) Has received dialysis or are expected to start dialysis within the next 3 months.
Participants needed: 80
Trial details
Age: 18+Biological sex: AllType: InterventionalSponsor: Fresenius Kabi Taiwan Ltd.Updated: Oct 1, 2026Locations: 2
Eligibility criteria
Not listed